Characterizing Breast Masses Using an Integrative Framework of Machine Learning and Radiomics
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure, Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
This clinical trial investigates the role of contrast enhanced ultrasound (CEUS) in identifying cystic breast masses as benign or malignant. Ultrasound is a diagnostic imaging test that uses sound waves to make pictures of the body without using radiation (x-rays). Ultrasounds are widely used to diagnose many diseases in the body. This trial may help researchers learn if using CEUS will help in determining whether or not an ultrasound guided biopsy is necessary.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Newly diagnosed breast masses assigned as BIRADS 4a, 4b, 4c or 5 by conventional US and recommended for ultrasound guided biopsy
• Age \>= 18 years
• Female
Locations
United States
California
Los Angeles County-USC Medical Center
RECRUITING
Los Angeles
USC / Norris Comprehensive Cancer Center
RECRUITING
Los Angeles
Contact Information
Primary
Janet Jaime
Janet.jaime@med.usc.edu
323-865-3205
Time Frame
Start Date: 2020-11-05
Estimated Completion Date: 2027-11-05
Participants
Target number of participants: 100
Treatments
Experimental: Diagnostic (contrast agent, CEUS)
Patients receive a contrast tracer (Lumason or DEFINITY) IV and then undergo CEUS scan over 60-90 minutes.
Related Therapeutic Areas
Sponsors
Leads: University of Southern California
Collaborators: National Cancer Institute (NCI)